ASH 2023: Exploring Therapeutic Advancements for Chronic Lymphocytic Leukemia - Episode 1
Catherine Coombs, MD discusses the present CLL front-line treatment landscape, addressing considerations like choosing fixed-duration or continuous therapy and variations in first-line approaches based on age and ECOG status.